MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjresp-2022-001227

Медицинская библиотека · BMJ open respiratory research · 2022

Frailty assessment for COVID-19 follow-up: a prospective cohort study.

Müller Ilena, Mancinetti Marco, Renner Anja, Bridevaux Pierre-Olivier, Brutsche Martin H, Clarenbach Christian, Garzoni Christian, Lenoir Alexandra, Naccini Bruno, Ott Sebastian, Piquilloud Lise, Prella Maura, Que Yok-Ai, Soccal Paola Marina, von Garnier Christophe, Geiser Thomas K, Funke-Chambour Manuela, Guler Sabina

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The Clinical Frailty Scale (CFS) is increasingly used for clinical decision making in acute care but little is known about frailty after COVID-19.

OBJECTIVES

To investigate frailty and the CFS for post-COVID-19 follow-up.

METHODS

This prospective multicentre cohort study included COVID-19 survivors aged ≥50 years presenting for a follow-up visit ≥3 months after the acute illness. Nine centres retrospectively collected pre-COVID-19 CFS and prospectively CFS at follow-up. Three centres completed the Frailty Index (FI), the short physical performance battery (SPPB), 30 s sit-to-stand test and handgrip strength measurements. Mixed effect logistic regression models accounting for repeated measurements and potential confounders were used to investigate factors associated with post-COVID-19 CFS. Criterion and construct validity were determined by correlating the CFS to other concurrently assessed frailty measurements and measures of respiratory impairment, respectively.

RESULTS

Of the 288 participants 65% were men, mean (SD) age was 65.1 (9) years. Median (IQR) CFS at follow-up was 3 (2-3), 21% were vulnerable or frail (CFS ≥4). The CFS was responsive to change, correlated with the FI (r=0.69, p<0.001), the SPPB score (r=-0.48, p<0.001) (criterion validity) and with the St George's Respiratory Questionnaire score (r=0.59, p<0.001), forced vital capacity %-predicted (r=-0.25, p<0.001), 6 min walk distance (r=-0.39, p<0.001) and modified Medical Research Council (mMRC) (r=0.59, p<0.001). Dyspnoea was significantly associated with a higher odds for vulnerability/frailty (per one mMRC adjusted OR 2.01 (95% CI 1.13 to 3.58), p=0.02).

CONCLUSIONS

The CFS significantly increases with COVID-19, and dyspnoea is an important risk factor for post-COVID-19 frailty and should be addressed thoroughly.

Для цитирования: Müller Ilena, Mancinetti Marco, Renner Anja, Bridevaux Pierre-Olivier, Brutsche Martin H, Clarenbach Christian, Garzoni Christian, Lenoir Alexandra, Naccini Bruno, Ott Sebastian, Piquilloud Lise, Prella Maura, Que Yok-Ai, Soccal Paola Marina, von Garnier Christophe, Geiser Thomas K, Funke-Chambour Manuela, Guler Sabina. Frailty assessment for COVID-19 follow-up: a prospective cohort study.. BMJ open respiratory research. 2022. DOI: 10.1136/bmjresp-2022-001227.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.